Found 7 matching trials
Efficacy and Safety of Oral Encochleated Amphotericin B for the Treatment of Cryptococcal Infection PHASE1 This will be an open label phase I/II prospective cohort study to determine...
Show More Location
Multiple Locations
Learn More & Join Trial
CAMB/MAT2203 in Patients With Mucocutaneous Candidiasis PHASE2 This is an open-label, dose-titration trial to study the efficacy, safety, ...
Show More Location
National Institute of Allergy and Infectious Disease (NIAID)
Learn More & Join Trial
Encochleated Oral Amphotericin for Cryptococcal Meningitis Trial 3 PHASE3 This pivotal, confirmatory trial seeks to independently verify the results ...
Show More Location
Multiple Locations
Learn More & Join Trial
Safety and PK of Oral Encochleated Amphotericin B (CAMB/MAT2203) for Antifungal Prophylaxis in Patients Undergoing Induction Chemotherapy for Acute Myelogenous and Lymphoblastic Leukaemia PHASE2 A Non-randomized, prospective , multicenter, open uncontrolled study in pat...
Show More Location
Multiple Locations
Learn More & Join Trial
Safety and Efficacy of Oral Encochleated Amphotericin B (CAMB/MAT2203) in the Treatment of Vulvovaginal Candidiasis (VVC) PHASE2 This is a multi-center, randomized study to evaluate the safety, tolerabili...
Show More Location
Alabama Clinical Therapeutics
Learn More & Join Trial
Encochleated Oral Amphotericin for Cryptococcal Meningitis Trial (EnACT) PHASE1 This study is designed as two sequential trials. The first is a phase I ope...
Show More Location
Infectious Disease Institute
Learn More & Join Trial
Efficacy and Safety of Oral Encochleated Amphotericin B (CAMB) in the Treatment of Fluconazole-Resistant Vulvovaginal Candidiasis PHASE2 This is a single-center, open-label, pilot study to evaluate the efficacy o...
Show More Location
Tolan Park Clinic
Learn More & Join Trial